Pharmaron Beijing Co., Ltd. (300759.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 50.09B |
| Enterprise Value | 52.49B |
| P/E Ratio | 44.65 |
| PEG Ratio | 2.71 |
| Price/Sales Ratio | 4.08 |
| Price/Book Ratio | 4.8 |
| Enterprise/Revenue | 4.35 |
| Enterprise/EBITDA | 19.37 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.14 |
| Return On Assets | 0.05 |
| Return On Equity | 0.11 |
| Revenue | 14.1B |
| Revenue/Share | 8.73 |
| Gross Profit | 4.89B |
| EBITDA | 3.32B |
| Net Income | 1.66B |
| Diluted EPS | 0.94 |
| Total Cash | 4.03B |
| Total Cash/Share | 2.2 |
| Total Debt | 7.47B |
| Total Debt/Equity | 0.44 |
| Current Ratio | 1.04 |
| Book Value Per Share | 9.59 |
| 52-Week Change | 42.44 |
| 52-Week High | 53.57 |
| 52-Week Low | 21.01 |
| Moving Average 50 Days | 42.3 |
| Moving Average 200 Days | 34.12 |
| Average Volume | 52.22M |
| Shares Outstanding | 1.48B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.45 |
| Payout Ratio | 0.33 |
| Last Split Factor | 3:2 |
| Last Split Date | July 27, 2023 |